Endo Pharmaceuticals   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Malvern PA United States (1997)
Status: Acquired by DuPont (1970) → now Bristol-Myers Squibb (2001)

Organization Overview

First Clinical Trial
1997
NCT01316874
First Marketed Drug
1997
acetylsalicylic acid (aspirin)
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Endo | ENDO GLOBAL AESTHETICS LTD | ENDO PHARM | Endo Pharmaceuticals | Endo Pharmaceuticals (formerly Valera/Indevus Pharmaceuticals) | EndoPharmceuticals | Endo Pharmceuticals | ENDO PHARMS | ENDO PHARMS INC | Endo (v1) | Endo (v2) | ENDO VENTURES | ENDO VENTURES LTD